Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2010-07-23

FDA Approved: TRIBENZOR — Original Application (Cosette Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved Cosette Pharmaceuticals' original application for Tribenzor, a triple combination antihypertensive therapy consisting of olmesartan medoxomil, …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TRIBENZOR (OLMESARTAN MEDOXOMIL / AMLODIPINE BESYLATE / HYDROCHLOROTHIAZIDE)

Snippet

ORIG AP for TRIBENZOR (OLMESARTAN MEDOXOMIL / AMLODIPINE BESYLATE / HYDROCHLOROTHIAZIDE)